The short-read sequencing market is booming, projected to reach $26.87 billion by 2033, with a CAGR of 16.4%. Driven by advancements in NGS technology, decreasing costs, and expanding applications in diagnostics and research, this comprehensive market analysis explores key trends, major players (Illumina, Thermo Fisher, BGI), and future growth potential.
We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.